Titan America SA Common Shares (TTAM)
14.76
+0.02 (0.14%)
NYSE · Last Trade: Nov 1st, 2:44 AM EDT

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest opening, just slightly higher than its initial pricing.
Via Talk Markets · February 9, 2025
